Historically the pharmaceutical industry has measured the success of promotional spending by their ability to ensure that patients fill scripts. It’s time to move past that.
This week the Commonwealth Fund released a report ranking the U.S. last—among 11 other developed nations—in quality of healthcare, despite having the highest per-capita spending.
Payers—both private and, with the passage of healthcare reform, government funded programs....